Skip to main content

Table 1 Candidate Selection Criteria for cBMA Treatment

From: Injections of concentrated bone marrow aspirate as treatment for Discogenic pain: a retrospective analysis

Inclusion Criteria (n = 33)

 • Refractory LBP displaying discogenic degenerative changes via MRI

 • Positive concordant or partial concordant pain on discography and demonstrated internal disc disruption via CT scan (1, 2, or 3-level disc pathology accepted)

 • ≥ 50% disc height maintained at level(s) of treatment

 • No responsiveness to conservative therapy

 • Subjective findings of chronic LBP suggestive of discogenic etiology

 • Patients treated between Apr 2010 – Apr 2015

 • Patients desiring to be treated with concentrated autologous bone marrow aspirate at the level(s) of treatment

Exclusion Criteria

 • LBP caused by any other etiologies (facet pain, stenosis, etc.)

 • < 50% disc height maintained at level(s) of treatment

 • Full-thickness tears

 • Patients who underwent any additional therapies during the follow up period